Statistics
Publications
3
Citations
289
H-Index
3
Active since
2011
Affiliations
Johns Hopkins University(Current)
Allison Galanis is an author at Johns Hopkins University specializing in oncology, radiation oncology, and tumor biology.
Publications per year
2011–2014
3
3
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants
Allison Galanis, Hayley Ma, Trivikram Rajkhowa et al. · Blood · 2013 · 247 citations · Full text
The Novel Inhibitor PLX3397 Effectively Inhibits FLT3-Mutant AML,
Elizabeth A. Burton, Bernice H. Wong, Jiazhong Zhang et al. · Blood · 2011 · 16 citations
1–3 of 3